These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2646365)

  • 1. Glucose and insulin metabolism in cirrhosis.
    Petrides AS; DeFronzo RA
    J Hepatol; 1989 Jan; 8(1):107-14. PubMed ID: 2646365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations.
    Nielsen MF; Caumo A; Aagaard NK; Chandramouli V; Schumann WC; Landau BR; Schmitz O; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1135-43. PubMed ID: 15637182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
    Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
    Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment.
    Marchesini G; Pacini G; Bianchi G; Patrono D; Cobelli C
    Gastroenterology; 1990 Dec; 99(6):1715-22. PubMed ID: 2227285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].
    Petrides AS
    Z Gastroenterol; 1999 Jun; Suppl 1():15-21. PubMed ID: 10444811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing early insulin secretion compensate adequately for hepatic insulin resistance in CCl4-induced cirrhosis rats.
    Arai H; Awane N; Mizuno A; Fukaya M; Sakuma M; Harada N; Kawaura A; Yamamoto H; Okumura H; Taketani Y; Doi T; Takeda E
    J Med Invest; 2010 Feb; 57(1-2):54-61. PubMed ID: 20299743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in cirrhosis: a review with some perspectives for the future.
    Petrides AS; DeFronzo RA
    Diabetes Metab Rev; 1989 Dec; 5(8):691-709. PubMed ID: 2693018
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
    Antoniello S; La Rocca S; Cavalcanti E; Auletta M; Salvatore F; Cacciatore L
    Clin Chim Acta; 1989 Aug; 183(3):343-50. PubMed ID: 2680168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of NIDDM. A balanced overview.
    DeFronzo RA; Bonadonna RC; Ferrannini E
    Diabetes Care; 1992 Mar; 15(3):318-68. PubMed ID: 1532777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
    Bahr MJ; Boeker KH; Manns MP; Tietge UJ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.
    Letiexhe MR; Scheen AJ; Gérard PL; Bastens BH; Pirotte J; Belaiche J; Lefèbvre PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1263-8. PubMed ID: 8077319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.
    Greco AV; Mingrone G; Mari A; Capristo E; Manco M; Gasbarrini G
    Gut; 2002 Dec; 51(6):870-5. PubMed ID: 12427792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis.
    Imano E; Kanda T; Nakatani Y; Motomura M; Arai K; Matsuhisa M; Yamasaki Y; Hori M
    J Hepatol; 1999 Sep; 31(3):469-73. PubMed ID: 10488706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic cirrhosis (non hemochromatosic) Diabetes mellitus. III. Secretion of insulin in cirrhotic patients tolerant and non tolerant to oral glucose overload].
    Cerdán Vallejo A; Jolin Buzo T; Sánchez Franco F; Ortíz Vázquez J
    Rev Clin Esp; 1974 Sep; 134(5):441-8. PubMed ID: 4438739
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.
    Selberg O; Burchert W; vd Hoff J; Meyer GJ; Hundeshagen H; Radoch E; Balks HJ; Müller MJ
    J Clin Invest; 1993 May; 91(5):1897-902. PubMed ID: 8486761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin action in uremia.
    DeFronzo RA; Smith D; Alvestrand A
    Kidney Int Suppl; 1983 Dec; 16():S102-14. PubMed ID: 6376911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.